本論壇聚焦於以製造與法規為核心的藥物韌性建構路徑，從國際法規趨勢出發，並探討QbDD與Digital CMC 如何成為提升藥品供應穩定性與系統韌性的基礎能力，透過實際製程開發、Scale-up 與 CDMO產業實務，說明韌性如何在製造端被具體化與落地。

同時，論壇延伸至高風險、高複雜度藥品所面臨的挑戰，檢視從臨床設計、製程穩健性、法規合規到商業化的系統性議題，並納入醫療體系第一線視角，強調藥物韌性不僅是產業或製造議題，更是整體醫療系統工程。此外，論壇亦納入健保制度視角，說明其在藥品供應穩定與病人用藥安全中的支撐角色，作為連結醫療體系與產業供應鏈的重要制度節點。

透過監管機關、產業實務、健保制度與臨床端的對話，本論壇旨在勾勒出台灣在全球藥物韌性價值鏈中可扮演的關鍵角色。

----115年5月19日----
09:00-09:20 Opening Remarks &Group Photo Session(Ministry of Economic Affairs)
09:20-09:50 Building Taiwan's Drug Supply Chain Resilience: Leveraging Global Strategic Support(Chien-Cheng Tai,Senior Specialist, MOEA)
09:50-10:20 Future Trends in Building Pharmaceutical Resilience(Stephen M. Hahn, CEO,Nucleus RadioPharma)
10:20-10:40 TFDA Regulatory Strategies to Enable Pharmaceutical Supply Chain Resilience and GMP Reliance(Lan-Hui Chih,Division Director,TFDA, MOHW)
10:40-11:00 Break
11:00-11:20 Strengthening Manufacturing Resilience and Global Competitiveness of the Generic Drug Industry Through Digital Transformation and QbDD(Tiffany Chen, President,Taiwan Generic Pharmaceutical Association)
11:20-11:50 Panel Discussion(Moderator:Eric Y. Chuang, Senior Technology Expert,BDL,ITRI)

13:30-13:40 Opening Remarks & Group Photo Session(Maggie Lu, VP& General Director, BDL, ITRI)
13:40-14:10 From Process Innovation to Industrial Scale-Up: A Perspective from CPI, UK.(Arun Harish, Chief Strategy Officer, Center of Processing Innovation)
14:10-14:30 Supporting Pharmaceutical Resilience: The Role of National Health Insurance across Healthcare and Supply Chains(Chia-Jui Yen,Deputy Director-eneral,
National Health Insurance Administration, Ministry of Health and Welfare)
14:30-14:50 From Drug Shortages to Patient Safety: A Hospital Frontline Perspective on Pharmaceutical Resilience(Li-Jiuan Shen,Secretary General / Professor, ational Taiwan University)
14:50-15:10 Break
15:10-15:30 From Manufacturing Reliability to Pharmaceutical Resilience:Key Strategies of a Leading CDMO(Nick Liu, General Manager,TWi Pharmaceuticals)
15:30-16:00 Panel Discussion(Moderator:Maggie Lu, VP& General Director, BDL, ITRI)